Author:
Katagi Jun,Nakamura Yuji,Cao Xin,Ohara Hiroshi,Honda Atsushi,Izumi-Nakaseko Hiroko,Ando Kentaro,Sugiyama Atsushi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference29 articles.
1. The ICH Steering Committee. The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals (S7B), The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), The Guideline was recommended for adoption at Step 5 of the ICH process in May 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7B/Step4/S7B_Guideline.pdf . Accessed December 21, 2014.
2. Darpo, B. (2010). The thorough QT study four years after the implementation of the ICH E14 guidance. British Journal of Pharmacology, 159, 49–57.
3. Sugiyama, A., Hashimoto, H., Nakamura, Y., Fujita, T., & Kumagai, Y. (2014). QT/QTc study conducted in Japanese adult healthy subjects: A novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation. Journal of Clinical Pharmacology, 54, 446–452.
4. Sakaguchi, Y., Sugiyama, A., Takao, S., Akie, Y., Takahara, A., & Hashimoto, K. (2005). Halothane sensitizes the guinea-pig heart to pharmacological IKr blockade: Comparison with urethane anesthesia. Journal of Pharmacological Sciences, 99, 185–190.
5. Sakaguchi, Y., Takahara, A., Nakamura, Y., Akie, Y., & Sugiyama, A. (2009). Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation. Basic & Clinical Pharmacology & Toxicology, 104, 43–48.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献